Skin Prick Test: How It Works and What Results Mean

The skin prick test (SPT) is one of the most widely used first-line diagnostic tools in clinical allergy evaluation, capable of producing results within 15 to 20 minutes in an office setting. It works by introducing a small amount of a suspect allergen into the outer layer of skin and measuring the body's immune response. Understanding how the test is administered, how results are interpreted, and where its diagnostic limits lie helps patients and clinicians make informed decisions about next steps in allergy care.

Definition and Scope

The skin prick test is a Type I hypersensitivity screening procedure that detects IgE-mediated allergic sensitization. When a sensitized individual has skin contact with a specific allergen extract, mast cells in the skin degranulate and release histamine, producing a localized wheal-and-flare reaction at the test site.

The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) both recognize SPT as a standard component of the allergy diagnosis process. Allergen extracts used in SPT are regulated as biological products by the U.S. Food and Drug Administration under 21 CFR Part 680, which governs allergenic products manufacturing and potency standards.

SPT can screen for sensitization across broad allergen categories, including:

The test does not diagnose clinical allergy on its own. A positive result indicates sensitization — the presence of allergen-specific IgE — not necessarily that a patient will experience symptoms upon natural exposure. Context from a full allergy diagnosis process is required to interpret any SPT result meaningfully.

How It Works

The procedure follows a standardized sequence that minimizes variability and maximizes reproducibility.

  1. Site preparation — The volar (inner) surface of the forearm, or occasionally the upper back, is cleaned with alcohol and allowed to dry. The forearm permits easier reading of multiple test sites simultaneously.
  2. Allergen application — Small drops of standardized allergen extracts are placed on the skin surface, spaced at least 2 centimeters apart to prevent overlapping reactions. A positive control (histamine, typically at 1 mg/mL or 10 mg/mL concentration) and a negative control (saline or glycerinated saline) are applied alongside the test allergens.
  3. Skin disruption — A lancet or bifurcated needle is pressed through each extract drop at a 90-degree angle with a standardized depth of approximately 1 millimeter, introducing a micro-quantity of extract into the epidermis. No bleeding should occur.
  4. Reading window — The patient remains still for 15 to 20 minutes. After that interval, the technician or physician measures wheal diameter (the raised, firm center) and flare diameter (the surrounding redness) at each site. A ruler or dermatograph pen is used to record measurements in millimeters.
  5. Result threshold — A wheal diameter of 3 mm or greater than the negative control is generally considered a positive result, per practice parameters published jointly by the AAAAI and ACAAI (Joint Task Force on Practice Parameters).

Medications that suppress histamine response must be withheld before testing. Oral antihistamines typically require a 3- to 7-day washout period. Tricyclic antidepressants may require up to 10 days. The clinician determines the washout schedule based on the specific agent. Topical corticosteroids applied to the test site can also suppress reaction size and should be avoided in the days preceding testing.

Common Scenarios

SPT is applied across a range of clinical presentations. Three situations represent the most frequent use cases.

Suspected environmental allergies — A patient reporting allergic rhinitis symptoms during specific seasons or year-round may undergo SPT to a panel of regional aeroallergens. A positive result to, say, timothy grass pollen combined with symptom timing consistent with grass pollen season supports a diagnosis of seasonal allergic rhinitis. Negative results across the entire panel may redirect evaluation toward nonallergic rhinitis.

Suspected food allergy in children — SPT is commonly used in pediatric food allergy evaluation, particularly for the food allergies most likely to cause IgE-mediated reactions. The AAAAI notes that a wheal size of 8 mm or greater for peanut SPT in children carries a high positive predictive value, though cutoff values differ by food and patient age. Results are interpreted alongside dietary history and, when indicated, a supervised oral food challenge.

Insect venom sensitivity — Following an anaphylactic reaction to an insect sting, SPT to venom extracts helps identify the responsible species and confirm candidacy for venom immunotherapy. The test is performed after a minimum recovery interval — typically 4 to 6 weeks post-reaction — because systemic reactions can temporarily deplete skin-sensitizing IgE.

Decision Boundaries

SPT has defined performance characteristics that set its appropriate diagnostic role. The test carries a sensitivity generally reported between 70% and 95% depending on allergen type and extract standardization, and specificity that varies similarly. These figures are drawn from meta-analyses summarized in AAAAI and ACAAI practice guidelines rather than a single study, and vary meaningfully across allergen categories.

SPT versus allergen-specific IgE blood testing — The primary alternative to SPT is serum allergen-specific IgE measurement (ImmunoCAP or equivalent), detailed in the resource on allergy blood tests explained. SPT offers faster results, lower per-test cost, and the ability to test a broad panel simultaneously. Serum testing is preferred when patients cannot safely discontinue antihistamines, when widespread skin conditions such as eczema and atopic dermatitis cover the test site, or when a patient's dermographism (skin that weals in response to mechanical pressure alone) would invalidate SPT readings.

False positives and false negatives — A positive SPT to a food allergen does not establish that the patient reacts clinically to that food. Studies cited in ACAAI guidance indicate that up to 50–60% of positive SPT results to foods are not associated with clinical reactions, meaning a positive result alone is insufficient to restrict diet without further evaluation. False negatives can occur with degraded or poorly standardized extracts, inadequate skin reactivity (common in very young infants or elderly patients), or antihistamine suppression.

Safety profile — SPT carries a low systemic reaction risk when performed in a clinical setting equipped for emergency response. The AAAAI Joint Task Force parameters classify SPT-induced anaphylaxis as rare, estimated at fewer than 1 systemic reaction per 1 million tests administered, though local reactions producing large wheals are more common. Testing should not be performed during periods of unstable asthma or acute allergic illness. The regulatory context for allergy practice in the United States provides the broader framework under which allergen extracts and testing procedures are governed, including FDA oversight of extract biologics.

When SPT results align with clinical history, they support decisions about allergy immunotherapy candidacy, environmental avoidance planning outlined in allergy avoidance strategies, and medication selection. When results conflict with history, additional diagnostic steps — including supervised oral food challenge, component-resolved diagnostics, or repeat testing under optimized conditions — are typically indicated.

Patients seeking foundational orientation to allergy evaluation can find a broad overview of the field at Allergy Authority, which covers the full scope of allergy types, triggers, and diagnostic pathways.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)